Related Experiment Video

Updated: Apr 23, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.9K

Demographics and clinical characteristics of multiple sclerosis in Kuwait

Raed Alroughani1, S F Ahmed, J Al-Hashel

  • 1Division of Neurology, Department of Medicine, Amiri Hospital, Kuwait, Kuwait.

European Neurology
|September 18, 2014
PubMed

Insights

This study analyzed 736 multiple sclerosis (MS) patients in Kuwait, revealing distinct clinical characteristics and early disease presentations compared to regional data. Findings highlight unique demographic and symptom patterns in Kuwaiti MS patients.

Area of Science:

  • Neurology
  • Epidemiology
  • Clinical Research

Background:

  • Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • Understanding regional variations in MS demographics and clinical presentation is crucial for effective management.
  • Limited data exists on the specific characteristics of MS in the Middle Eastern population, particularly Kuwait.

Purpose of the Study:

  • To investigate the demographic and clinical features of multiple sclerosis (MS) in Kuwait.
  • To compare the onset symptoms and disease progression patterns of MS patients in Kuwait with regional cohorts.
  • To identify unique characteristics of MS within the Kuwaiti population.

Main Methods:

  • Retrospective analysis of data from 736 patients diagnosed with MS, sourced from two MS clinics in Kuwait.
  • Inclusion of patient demographics, age at onset, disease duration, presenting symptoms (cerebellar/brainstem, spinal), and Expanded Disability Status Scale (EDSS) scores.
  • Statistical analysis to determine mean values and percentages for key clinical and demographic parameters.

Main Results:

  • The study included 736 MS patients, with 77.7% exhibiting a relapsing-remitting course.
  • The mean age at onset was 26.87 years, and the mean disease duration was 7.71 years.
  • Cerebellar/brainstem (29.5%) and spinal (27.4%) manifestations were the most common presenting symptoms. 72.8% of patients had an EDSS score of ≤3.

Conclusions:

  • MS in Kuwait presents with distinct clinical characteristics, including specific onset symptoms and disease progression patterns, compared to other regional populations.
  • The findings underscore the importance of considering geographical variations in MS epidemiology and clinical expression.
  • Further research is warranted to explore the factors contributing to these observed differences in MS presentation and progression in Kuwait.

More Related Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.3K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.6K

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
9
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
755
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K